Kevin Y. H. Wang
Biography
Kevin Wang is the Head of the Corporate/M&A and Healthcare practice and industry group at the Taipei office. With over 30 years of experience, Kevin possesses solid industry knowledge in handling complex mergers and acquisition transactions, related merger filings, foreign investment matters, international trade, general corporate issues, and healthcare industry matters. He also focuses on providing strategic advice, deal structuring, navigating local requirements, negotiations, and risk management.
Representative Legal Matters
- Advised Stanley Black & Decker in its USD 150 million acquisition of Compass Corporation, a major Taiwanese hand tool manufacturer.
- Advised Unilever in the spin-off its USD 5 billion global tea business to newly incorporated Ekaterra.
- Advised Becton Dickinson in the spin-off of its global diabetes healthcare business, with an annual revenue of over USD 1.1 billion, for sale to a new buyer.
- Advised GSK in the spin-off and bidding of its healthcare products manufacturing facility.
- Advised Eastern Media Group in its HKD 1 billion acquisition of HK listed Natural Beauty Biotechnology.
- Advised the owner of LeYou, the second-largest baby products chain store in China, in the sale of the company to Warburg Pincus for USD 200 million.
- Advised Dow in its merger of Dow Corning and the legal entity reorganization.
- Advised Eastern Media Group in its sale of Eastern Broadcasting Corporation together with Carlyle to MaoDe Group for a total deal value of USD 570 million.
- Advised Medtronic in its acquisition of Covidien.
- Advised GSK in its spin-off, acquisition and regroup of the Ox, Cx and Vx business with Novartis.
Professional Honors
- Named Taiwan’s Top 100 Lawyers by Asia Business Law Journal (2025)
- Named Recognized Practitioner by Chambers Greater China (2025)
- Named Hall of Fame Individual by The Legal 500 Asia Pacific (2024)
- Named Highly Regarded by IFLR1000 (2024)
Professional Associations and Memberships
- New York State Bar Association (registered in 1992)
- Advisor, Ministry of Mainland China Affairs on investment issues (1988-present)
- Commissioner, Internal Review Board (IRB) of Chang Gung Memorial Hospital (2009-present)
- External Commissioner, Ethical Commission of BioBank of Chang Gung Memorial Hospital, Keelung Branch (2012-present)
Admissions
- New York~United States (1992)
Education
- New York University (M.C.J.) (1991)
- American University (LL.M.) (1989)
- National Chung-Hsing University (LL.B.) (1985)
Languages
- Chinese
- English
Previous Offices
- Hong Kong
Baker & McKenzie, a Taiwanese Partnership, is a member of Baker & McKenzie International, a Swiss Verein.